Amedeo Smart

Free Medical Literature Service

 

Amedeo

Diabetes
  Free Subscription

Articles published in
J Diabetes Complications
    April 2024
  1. GRACIA-RAMOS AE, Cruz-Dominguez MDP, Madrigal-Santillan EO, Rojas-Martinez R, et al
    Efficacy and safety of sitagliptin with basal-plus insulin regimen versus insulin alone in non-critically ill hospitalized patients with type 2 diabetes: SITA-PLUS hospital trial.
    J Diabetes Complications. 2024;38:108742.
    >> Share

  2. FILARDI T, Feraco A, Ouvrard-Pascaud A, Rizzo M, et al
    Managing cardio-renal-metabolic risk in patients with type 2 diabetes: the role of finerenone.
    J Diabetes Complications. 2024;38:108741.
    >> Share

  3. LASSCHUIT JWJ, Center JR, Greenfield JR, Tonks KTT, et al
    Effect of denosumab on inflammation and bone health in active Charcot foot: A phase II randomised controlled trial.
    J Diabetes Complications. 2024;38:108718.
    >> Share

  4. RAKOTOARISOA L, Weiss L, Lefebvre F, Porzio M, et al
    Early glucose abnormalities revealed by continuous glucose monitoring associate with lung function decline in cystic fibrosis: A five-year prospective study.
    J Diabetes Complications. 2024;38:108703.
    >> Share

    March 2024
  5. FARAH R, Alhajahjeh A, Al-Farahid O, Abuzaid H, et al
    Risk factors for chronic kidney disease in middle eastern patients with type 2 diabetes mellitus: A cross-sectional study using the KDIGO classification.
    J Diabetes Complications. 2024;38:108740.
    >> Share

  6. FONSECA LM, Kanapka L, Miller K, Pratley R, et al
    Risk factors associated with cognitive performance and cognitive impairment in older adults with type 1 diabetes: Data from the Wireless Innovation for Seniors with Diabetes Mellitus (WISDM) study.
    J Diabetes Complications. 2024;38:108739.
    >> Share

  7. PINES-CORRALES PJ, Lopez-Garcia MC, Sanz-Velasco A, Moya-Moya AJ, et al
    Changes in glucometric parameters in people living with diabetes users of the free-style libre 2 system before and after the update possibility to real-time glucose readings in real world practice.
    J Diabetes Complications. 2024;38:108723.
    >> Share

  8. CAMPOS AC, Lima EG, Jacobsen PK, Arnould L, et al
    Association between obstructive coronary disease and diabetic retinopathy: Cross-sectional study of coronary angiotomography and multimodal retinal imaging.
    J Diabetes Complications. 2024;38:108721.
    >> Share

  9. TSUR N, Frankel M, Cahn A, Tsur A, et al
    Gestational diabetes and risk of future diabetes in a multi-ethnic population.
    J Diabetes Complications. 2024;38:108720.
    >> Share

  10. VUORLAAKSO M, Karen V, Kiiski J, Lahtela J, et al
    Multidisciplinary management of diabetic foot infection associated with improved 8-year overall survival.
    J Diabetes Complications. 2024;38:108719.
    >> Share

    February 2024
  11. MATSUURA S, Nagata S, Shibazaki K, Uchida R, et al
    Increased skeletal muscle mass index was involved in glycemic efficacy following diabetes treatment, and changes in fat mass index correlated with the changes in the lipid ratio in type 2 diabetes.
    J Diabetes Complications. 2024;38:108717.
    >> Share

  12. KONESHAMOORTHY A, Epa DS, O'Neal DN, Lee MH, et al
    Outcomes associated with a variable rate insulin infusion diabetic ketoacidosis protocol.
    J Diabetes Complications. 2024;38:108702.
    >> Share

  13. HSIA DS, Younes N, Krause-Steinrauf H, Kassem LS, et al
    The incidence of retinopathy in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness study (GRADE).
    J Diabetes Complications. 2024;38:108692.
    >> Share

  14. RAN GL, Li YP, Lu LC, Lan SH, et al
    Disease-modifying therapies for diabetic peripheral neuropathy: A systematic review and meta-analysis of randomized controlled trials.
    J Diabetes Complications. 2024;38:108691.
    >> Share

  15. GULLAKSEN S, Vernstrom L, Sorensen SS, Ringgaard S, et al
    The effects of semaglutide, empagliflozin and their combination on the kidney sodium signal from magnetic resonance imaging: A prespecified, secondary analysis from a randomized, clinical trial.
    J Diabetes Complications. 2024;38:108673.
    >> Share

    January 2024
  16. RUIZ-MUNOZ M, Martinez-Barrios FJ, Fernandez-Torres R, Lopezosa-Reca E, et al
    Autologous platelet-rich plasma (APRP) in diabetes foot disease: a meta-analysis.
    J Diabetes Complications. 2024;38:108690.
    >> Share

  17. ANNUZZI G, Triggiani R, De Angelis R, Rainone C, et al
    Delayed prandial insulin boluses are an important determinant of blood glucose control and relate to fear of hypoglycemia in people with type 1 diabetes on advanced technologies.
    J Diabetes Complications. 2024;38:108689.
    >> Share

  18. JIANG M, Yang Z, Lyu L, Shi M, et al
    Dapagliflozin attenuates renal fibrosis by suppressing angiotensin II/TGFbeta signaling in diabetic mice.
    J Diabetes Complications. 2024;38:108687.
    >> Share

  19. YAN Q, Li D, Jia S, Yang J, et al
    Novel gene-based therapeutic approaches for the management of hepatic complications in diabetes: Reviewing recent advances.
    J Diabetes Complications. 2024;38:108688.
    >> Share

  20. CHUANCHAIYAKUL N, Thongtang N, Rattanaumpawan P
    Corrigendum to "Cumulative incidence of and risk factors for herpes zoster among patients with diabetes mellitus: Results from a 10-year nested case-control study" [J Diabetes Complicat., Volume 36, Issue 5, May 2022, 108168].
    J Diabetes Complications. 2024;38:108674.
    >> Share

  21. LOW S, Ng TP, Goh KS, Moh A, et al
    Reduced skeletal muscle mass to visceral fat area ratio is independently associated with reduced cognitive function in type 2 diabetes mellitus.
    J Diabetes Complications. 2024;38:108672.
    >> Share

    December 2023
  22. BLAIR YA, Doherty L, Temprosa M, Pop-Busui R, et al
    Prevalence and predictors of erectile dysfunction among men in the diabetes prevention program outcomes study.
    J Diabetes Complications. 2023;38:108669.
    >> Share

  23. AU A, Bajar BT, Wong BM, Daskivich LP, et al
    Systemic and ocular outcomes in patients with young-onset type 2 diabetes.
    J Diabetes Complications. 2023;38:108670.
    >> Share

  24. ZHANG H, Gu Y, Zhang K, Tu Y, et al
    Roles and mechanisms of umbilical cord mesenchymal stem cells in the treatment of diabetic foot: A review of preclinical and clinical studies.
    J Diabetes Complications. 2023;38:108671.
    >> Share

  25. GIANNAKOPOULOS A, Chrysanthakopoulou N, Efthymiadou A, Chrysis D, et al
    Diabetic ketosis vs ketoacidosis as initial presentation of pediatric type 1 diabetes mellitus. Associated features and rate of progression during the first two years after diagnosis.
    J Diabetes Complications. 2023;38:108667.
    >> Share

  26. SAHA CK, Shubrook JH, Guyton Hornsby W, Yang Z, et al
    Program ACTIVE II: 6- and 12-month outcomes of a treatment approach for major depressive disorder in adults with type 2 diabetes.
    J Diabetes Complications. 2023;38:108666.
    >> Share

  27. KOREI AE, Putz Z, Vagi OE, Tordai DZ, et al
    The handgrip test - A historical test for diabetic autonomic neuropathy or a marker of something else?
    J Diabetes Complications. 2023;38:108668.
    >> Share

  28. HANG X, Yu X, Fan S
    Lower extremity arterial plaque in patients with type 2 diabetes mellitus: A cross-sectional study of 25-(OH)D(3) and other risk factors.
    J Diabetes Complications. 2023;38:108665.
    >> Share

  29. IDREES T, Umpierrez GE
    Beyond pounds: What else could be lost?
    J Diabetes Complications. 2023;37:108649.
    >> Share

  30. MUZUROVIC E, Yumuk VD, Rizzo M
    GLP-1 and dual GIP/GLP-1 receptor agonists in overweight/obese patients for atherosclerotic cardiovascular disease prevention: Where are we now?
    J Diabetes Complications. 2023;37:108647.
    >> Share

    November 2023
  31. ROTBAIN CUROVIC V, Tavenier J, Ferreira-Divino LF, Poulsen CG, et al
    Soluble urokinase plasminogen activator receptor, platelet aggregation, and carotid plaque thickness in diabetes: A cross-sectional analysis.
    J Diabetes Complications. 2023;38:108654.
    >> Share

  32. DARIO P, Valentina P, Alessandro R, Stefano L, et al
    Von Willebrand factor hyperactivity affects the outcome of lower limb revascularization in subjects with type 2 diabetes mellitus complicated by diabetic foot vasculopathy: An observational pilot study.
    J Diabetes Complications. 2023;38:108653.
    >> Share

  33. TANENBAUM ML, Addala A, Hanes S, Ritter V, et al
    "It changed everything we do": A mixed methods study of youth and parent experiences with a pilot exercise education intervention following new diagnosis of type 1 diabetes.
    J Diabetes Complications. 2023;38:108651.
    >> Share

  34. WAKAMATSU S, Jojima T, Hashiguchi M, Kishi H, et al
    Inhibition of IL-33 signaling ameliorate hepatic fibrosis with decreasing MCP-1 in a mouse model of diabetes and non-alcoholic steatohepatitis; comparison for luseogliflozin, an SGLT2 inhibitor.
    J Diabetes Complications. 2023;38:108650.
    >> Share

  35. YANG C, Xiao C, Zhai X, Liu J, et al
    SGLT2 inhibitor improves kidney function and morphology by regulating renal metabolism in mice with diabetic kidney disease.
    J Diabetes Complications. 2023;38:108652.
    >> Share

  36. PIRAS DE OLIVEIRA C, Dellva MA, Bue-Valleskey J, Chang AM, et al
    Fasting and postprandial plasma glucose contributions to hemoglobin A1c and time in range in people with diabetes on multiple daily injection insulin therapy: Results from the PRONTO-T1D and PRONTO-T2D clinical trials.
    J Diabetes Complications. 2023;38:108648.
    >> Share

    October 2023
  37. DART AB, Sellers EAC, McGavock J, Del Vecchio M, et al
    24-h ambulatory blood pressure readings and associations with albuminuria in youth with type 2 diabetes: A cross sectional analysis from the iCARE cohort.
    J Diabetes Complications. 2023;37:108633.
    >> Share

  38. PAUNICA I, Mihai AD, Stefan S, Pantea-Stoian A, et al
    Comparative evaluation of LDL-CT, non-HDL/HDL ratio, and ApoB/ApoA1 in assessing CHD risk among patients with type 2 diabetes mellitus.
    J Diabetes Complications. 2023;37:108634.
    >> Share

  39. BALDIMTSI E, Whiss PA, Wahlberg J
    Systemic biomarkers of microvascular alterations in type 1 diabetes associated neuropathy and nephropathy - A prospective long-term follow-up study.
    J Diabetes Complications. 2023;37:108635.
    >> Share

  40. LI M, Liu Z, Yang X, Zhang J, et al
    The effect of sodium-glucose cotransporter 2 inhibitors as an adjunct to insulin in patients with type 1 diabetes assessed by continuous glucose monitoring: A systematic review and meta-analysis.
    J Diabetes Complications. 2023;37:108632.
    >> Share

  41. FAUZI A, Thoe ES, Quan TY, Yin ACY, et al
    Insights from insulin resistance pathways: Therapeutic approaches against Alzheimer associated diabetes mellitus.
    J Diabetes Complications. 2023;37:108629.
    >> Share

  42. XU C, Li H, Xu Q, Zhao K, et al
    Dapagliflozin ameliorated retinal vascular permeability in diabetic retinopathy rats by suppressing inflammatory factors.
    J Diabetes Complications. 2023;38:108631.
    >> Share

  43. MOLINUEVO MS, Cortizo AM, Sedlinsky C
    Effects of advanced glycation end-products, diabetes and metformin on the osteoblastic transdifferentiation capacity of vascular smooth muscle cells: In vivo and in vitro studies.
    J Diabetes Complications. 2023;37:108626.
    >> Share

  44. SHEN TH, Farley JF
    Utilization and impact of SLGT2 inhibitors among diabetes patients in a nationally representative survey: Findings from NHANES 2013-2020.
    J Diabetes Complications. 2023;37:108625.
    >> Share

  45. RITSINGER V, Hagstrom E, Hambraeus K, James S, et al
    Design and rationale of the myocardial infarction and new treatment with metformin study (MIMET) - Study protocol for a registry-based randomised clinical trial.
    J Diabetes Complications. 2023;37:108599.
    >> Share

  46. SUENAGA A, Sawa N, Oba Y, Ikuma D, et al
    Dipeptidyl peptidase-4 inhibitor-related renal disease.
    J Diabetes Complications. 2023;37:108590.
    >> Share

  47. GRIGGS S, Pignatiello G, Motairek I, Rieke J, et al
    Environmental exposures and blood pressure in adolescents and adults in the T1D exchange clinic registry.
    J Diabetes Complications. 2023;37:108594.
    >> Share

    September 2023
  48. DIAO H, Li X, Xu Y, Xing X, et al
    Asprosin, a novel glucogenic adipokine implicated in type 2 diabetes mellitus.
    J Diabetes Complications. 2023;37:108614.
    >> Share

  49. LU Y, Zhang Q, Wang X, Jiang Y, et al
    Usefulness of glucose management indicator derived from continuous glucose monitoring to assess glycemic condition in hospitalized patients with diabetic kidney disease treated with insulin pumps.
    J Diabetes Complications. 2023;37:108613.
    >> Share

  50. MELING S, Tjora E, Eichele H, Nedergaard RB, et al
    Corrigendum to "The PanGut-study: Evoked potentials following rectal balloon distention, a way of evaluating diabetic autonomic neuropathy in the gut?" [J. Diabetes Complicat., Volume 37, Issue 5, May 2023, 108452].
    J Diabetes Complications. 2023;37:108612.
    >> Share

  51. TOUGAARD NH, Hansen TW, Rossing P
    Vitamin D deficiency and development of complications in individuals with type 1 and type 2 diabetes: A cohort study.
    J Diabetes Complications. 2023;37:108611.
    >> Share

  52. O CK, Siu BW, Leung VW, Lin YY, et al
    Association of insomnia with incident chronic cognitive impairment in older adults with type 2 diabetes mellitus: A prospective study of the Hong Kong Diabetes Register.
    J Diabetes Complications. 2023;37:108598.
    >> Share

  53. MOLITCH ME, Tripputi M, Levey AS, Crandall JP, et al
    Effects of metformin and intensive lifestyle interventions on the incidence of kidney disease in adults in the DPP/DPPOS.
    J Diabetes Complications. 2023;37:108556.
    >> Share

  54. ROONEY MR, Daya NR, Leong A, McPhaul MJ, et al
    Prognostic value of insulin resistance and hyperglycemia biomarkers for long-term risks of cardiometabolic outcomes.
    J Diabetes Complications. 2023;37:108583.
    >> Share

  55. NAKHLEH A, Goldenberg-Furmanov M, Goldstein R, Shohat M, et al
    A beneficial role of GLP-1 receptor agonist therapy in ABCC8-MODY (MODY 12).
    J Diabetes Complications. 2023;37:108566.
    >> Share

  56. BAK ST, Haupt-Jorgensen M, Dudele A, Wegener G, et al
    The anti-inflammatory agent 5-ASA reduces the level of specific tsRNAs in sperm cells of high-fat fed C57BL/6J mouse sires and improves glucose tolerance in female offspring.
    J Diabetes Complications. 2023;37:108563.
    >> Share

  57. SHI M, Zhang H, Wang W, Zhang X, et al
    Effect of dapagliflozin on liver and pancreatic fat in patients with type 2 diabetes and non-alcoholic fatty liver disease.
    J Diabetes Complications. 2023;37:108610.
    >> Share

    August 2023
  58. LINDEKILDE N, Diaz LJ, Lasgaard M, Henriksen JE, et al
    Elevated risk of developing type 2 diabetes in people with a psychiatric disorder: What is the role of health behaviors and psychotropic medication?
    J Diabetes Complications. 2023;37:108591.
    >> Share

  59. HUANG L, Januszewski AS, Takahashi Y, O'Neal DN, et al
    Increased intracellular miR-142 in adults with Type 1 diabetes.
    J Diabetes Complications. 2023;37:108597.
    >> Share

  60. PEDERSEN FN, Stokholm L, Andersen N, Andresen J, et al
    Longitudinal bidirectional associations between diabetic retinopathy and diagnosed depression: Results from a Danish nationwide registry-based cohort study.
    J Diabetes Complications. 2023;37:108589.
    >> Share

  61. BORDERIE G, Foussard N, Larroumet A, Blanco L, et al
    The skin autofluorescence of advanced glycation end-products relates to the development of foot ulcers in type 2 diabetes: A longitudinal observational study.
    J Diabetes Complications. 2023;37:108595.
    >> Share

  62. KATAOKA Y, Kitahara S, Funabashi S, Makino H, et al
    The effect of continuous glucose monitoring-guided glycemic control on progression of coronary atherosclerosis in type 2 diabetic patients with coronary artery disease: The OPTIMAL randomized clinical trial.
    J Diabetes Complications. 2023;37:108592.
    >> Share

  63. SKRIVER LKL, Nielsen MW, Walther S, Norlev JD, et al
    Factors associated with adherence or nonadherence to insulin therapy among adults with type 2 diabetes mellitus: A scoping review.
    J Diabetes Complications. 2023;37:108596.
    >> Share

  64. YUAN Y, Zhou X, Ji L
    Association between remnant cholesterol level and severity of chronic kidney disease in patients with type 2 diabetes.
    J Diabetes Complications. 2023;37:108585.
    >> Share

  65. KRAMER BK, Hauske SJ, Chilton R, Mann JFE, et al
    Changes in cardiac and vascular haemodynamics as potential mediators of improvements in cardiovascular and kidney outcomes with empagliflozin in type 2 diabetes.
    J Diabetes Complications. 2023;37:108588.
    >> Share

  66. STAMATI A, Sotiriou G, Dimitriadou M, Christoforidis A, et al
    Efficacy and safety of faster aspart in insulin pumps in children and adolescents with type 1 diabetes mellitus: A single-center study with real-world data.
    J Diabetes Complications. 2023;37:108587.
    >> Share

  67. HERMANYI Z, Csiki V, Menyhart A, Osgyan K, et al
    How to evaluate over 60 million blood glucose data - The design of the MERY Diabetes Database.
    J Diabetes Complications. 2023;37:108586.
    >> Share

  68. MAINAS G, Nibali L, Rizzo M
    Is subclinical cardiovascular disease linked with periodontal disease in diabetic and non-diabetic subjects?
    J Diabetes Complications. 2023;37:108580.
    >> Share

  69. GOMEZ-PERALTA F, Abreu C, Rizzo M
    GLP-1 receptor agonists and SGLT2 inhibitors: The need to shed light on their safety risks real dimension and possible mechanisms.
    J Diabetes Complications. 2023;37:108553.
    >> Share

  70. HUANG W, Whitelaw J, Kishore K, Neto AS, et al
    The epidemiology of ketosis and low bicarbonate concentration in inpatients treated with sodium-glucose linked cotransporter inhibitors or dipeptidyl peptidase-4 inhibitors.
    J Diabetes Complications. 2023;37:108522.
    >> Share

    July 2023
  71. RORTH R, Kriegbaum M, Grand MK, Jacobsen PK, et al
    Risk of atrial fibrillation in individuals with dysglycemia and diabetes.
    J Diabetes Complications. 2023;37:108579.
    >> Share

  72. XIAO Q, Wang D, Li D, Huang J, et al
    Protein kinase C: A potential therapeutic target for endothelial dysfunction in diabetes.
    J Diabetes Complications. 2023;37:108565.
    >> Share

  73. FENG RQ, Xu MY, Feng RY, Zhang L, et al
    Serum Isthmin-1 is negatively correlated with HDL-C in type 2 diabetes mellitus.
    J Diabetes Complications. 2023;37:108567.
    >> Share

  74. ESMAEILZADEH A, Mohammadi V, Elahi R, Rezakhani N, et al
    The role of heat shock proteins (HSPs) in type 2 diabetes mellitus pathophysiology.
    J Diabetes Complications. 2023;37:108564.
    >> Share

  75. STIMSON RH, Dover AR, Strachan MWJ, Wright RJ, et al
    Associations between glucagon prescribing, hospital admissions for hypoglycaemia and continuous glucose monitoring metrics in adults with type 1 diabetes.
    J Diabetes Complications. 2023;37:108561.
    >> Share

  76. SCARR D, Lovblom LE, Bjornstad P, Perkins BA, et al
    Estimated glomerular filtration rate calculated by serum creatinine lacks precision and accuracy in adults with type 2 diabetes with preserved renal function.
    J Diabetes Complications. 2023;37:108562.
    >> Share

  77. JIN Z, Yuan Y, Zheng C, Liu S, et al
    Effects of sodium-glucose co-transporter 2 inhibitors on liver fibrosis in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus: An updated meta-analysis of randomized controlled trials.
    J Diabetes Complications. 2023;37:108558.
    >> Share

  78. CONTRERAS M, Mesa A, Pueyo I, Claro M, et al
    Effectiveness of flash glucose monitoring in patients with type 1 diabetes and recurrent hypoglycemia between early and late stages after flash glucose monitoring initiation.
    J Diabetes Complications. 2023;37:108560.
    >> Share

  79. COELHO PM, Simmer LM, da Silva DS, Dos Santos MC, et al
    Type 2 diabetes mellitus in obesity promotes prolongation of cardiomyocyte contractile function, impaired Ca(2+) handling and protein carbonylation damage.
    J Diabetes Complications. 2023;37:108559.
    >> Share

  80. GOH YA, Lan NSR, Linn K, Wood C, et al
    Comparison of coronary artery calcium score and cardiovascular risk-stratification by European Society of Cardiology Guidelines and Steno Type 1 Risk Engine in statin-naive adults with type 1 diabetes.
    J Diabetes Complications. 2023;37:108557.
    >> Share

  81. GRIFFIN KJ, Rashid TS, Bailey MA, Bird SA, et al
    Corrigendum to "Toe amputation: A predictor of future limb loss?" [J. Diabetes Complicat. 26(3) (May-Jun 2012) 251-4].
    J Diabetes Complications. 2023 Jul 6:108555. doi: 10.1016/j.jdiacomp.2023.108555
    >> Share

  82. KATSIKI N, Rizzo M, Mikhailidis DP
    Sodium-glucose co-transporter-2 (SGLT-2) inhibitors and uric acid: More good news!
    J Diabetes Complications. 2023;37:108510.
    >> Share

    June 2023
  83. LIAO M, Chen S, Guo R
    Association between carotid ultrasonographic parameters and microvascular and macrovascular complications in diabetes: A systematic review and meta-analysis.
    J Diabetes Complications. 2023;37:108554.
    >> Share

  84. PHAM RT, Pham-Hoang A, Lewis ST, Greenway F, et al
    Reversal of diabetic retinopathy in two patients following the use of physiologic insulin Resensitization.
    J Diabetes Complications. 2023;37:108549.
    >> Share

  85. TSUCHIDA K, Soda S, Rizzo M
    The legacy effect in early-stage diabetes: Don't stay by me, cardiovascular disease!
    J Diabetes Complications. 2023;37:108544.
    >> Share

  86. OZTURK NK, Cicek B, Tekin T, Gunturk I, et al
    Serum visfatin levels are positively correlated with dietary carbohydrate and polyunsaturated fatty acid intakes in type 2 diabetes mellitus patients.
    J Diabetes Complications. 2023;37:108550.
    >> Share

  87. OMUR SE, Zorlu C, Acikel B
    The effect of dapagliflozin therapy on ventricular repolarization parameters in electrocardiography in patients with diabetic cardiovascular disease.
    J Diabetes Complications. 2023;37:108547.
    >> Share

  88. MOORADIAN AD
    Diabetes-related perturbations in the integrity of physiologic barriers.
    J Diabetes Complications. 2023;37:108552.
    >> Share

  89. ALMEIDA EA, Mehndiratta M, Madhu SV, Kar R, et al
    PINK1 and oxidative stress in lean and obese patients with type 2 diabetes mellitus.
    J Diabetes Complications. 2023;37:108542.
    >> Share

  90. PRAMODKUMAR TA, Sivaprasad S, Venkatesan U, Mohan V, et al
    Role of cystatin C in the detection of sight-threatening diabetic retinopathy in Asian Indians with type 2 diabetes.
    J Diabetes Complications. 2023;37:108545.
    >> Share

  91. WILLIAMSON T, Gomez-Espinosa E, Stewart F, Dean BB, et al
    Poor adherence to clinical practice guidelines: A call to action for increased albuminuria testing in patients with type 2 diabetes.
    J Diabetes Complications. 2023;37:108548.
    >> Share

  92. BANERJEE Y, Patti AM, Giglio RV, Ciaccio M, et al
    The role of atherogenic lipoproteins in diabetes: Molecular aspects and clinical significance.
    J Diabetes Complications. 2023;37:108517.
    >> Share

  93. GRUBIC ROTKVIC P, Celap I, Bralic Lang V, Jug J, et al
    Impact of SGLT2 inhibitors on the mechanisms of myocardial dysfunction in type 2 diabetes: A prospective non-randomized observational study in patients with type 2 diabetes mellitus without overt heart disease.
    J Diabetes Complications. 2023;37:108541.
    >> Share

  94. HERMAN WH, Villatoro C, Joiner KL, McEwen LN, et al
    Retention and outcomes of National Diabetes Prevention Program enrollees and non-enrollees with prediabetes: The University of Michigan experience.
    J Diabetes Complications. 2023;37:108527.
    >> Share

  95. PATOULIAS D, Popovic DS, Stoian AP, Janez A, et al
    Effect of semaglutide versus other glucagon-like peptide-1 receptor agonists on cardio-metabolic risk factors in patients with type 2 diabetes: A systematic review and meta-analysis of head-to-head, phase 3, randomized controlled trials.
    J Diabetes Complications. 2023;37:108529.
    >> Share

  96. FOGACCI F, Rizzo M, Cicero AFG
    PUFA treatment in patients with gestational diabetes mellitus: Lights and shadows.
    J Diabetes Complications. 2023;37:108526.
    >> Share

  97. GUPTA A, Jeyaprakash P, Ghoreyshi-Hefzabad SM, Pathan F, et al
    Left ventricular longitudinal systolic dysfunction in children with type 1 diabetes mellitus: A systematic review and meta-analysis.
    J Diabetes Complications. 2023;37:108528.
    >> Share

  98. SIWAN E, Parry SN, Williams KH, McGill MJ, et al
    Circulating soluble CD163 as a potential biomarker of diabetes complications.
    J Diabetes Complications. 2023;37:108525.
    >> Share

  99. WU L, Zhao YY, Li MR, Chang DY, et al
    Clinical and pathological characteristics of DKD patients with early-onset type 2 diabetes.
    J Diabetes Complications. 2023;37:108520.
    >> Share

  100. CHENG Y, Wang H, Li M
    The promise of CRISPR/Cas9 technology in diabetes mellitus therapy: How gene editing is revolutionizing diabetes research and treatment.
    J Diabetes Complications. 2023;37:108524.
    >> Share

  101. DZHUN Y, Mankovsky G, Rudenko N, Marushko Y, et al
    Glycemic variability is associated with diastolic dysfunction in patients with type 2 diabetes.
    J Diabetes Complications. 2023;37:108519.
    >> Share

  102. CAI Z, Hu X, Gui L, Qi M, et al
    Study on the therapeutic effect and mechanism of Tangningtongluo Tablet on diabetic mice.
    J Diabetes Complications. 2023;37:108523.
    >> Share

    May 2023
  103. LIN H, Zhu J, Zheng C, Xu X, et al
    The correlation between visceral fat/subcutaneous fat area ratio and monocyte/high-density lipoprotein ratio in patients with type 2 diabetes mellitus and albuminuria.
    J Diabetes Complications. 2023;37:108521.
    >> Share

  104. HUHTALA MS, Ronnemaa T, Paavilainen E, Niinikoski H, et al
    Prediction of pre-diabetes and type 2 diabetes nine years postpartum using serum metabolome in pregnant women with gestational diabetes requiring pharmacological treatment.
    J Diabetes Complications. 2023;37:108513.
    >> Share

  105. LUO J, Tao Y, Xu Y, Yang L, et al
    Global comparison of the effect of non-pharmacological interventions on glycemic control in patients with type 2 diabetes: A network meta-analysis from 107 randomized controlled trials.
    J Diabetes Complications. 2023;37:108518.
    >> Share

  106. ADDALA A, Wong JJ, Penaranda RM, Hanes SJ, et al
    Expanding the use of patient-reported outcomes (PROs): Screening youth with type 1 diabetes from underrepresented populations.
    J Diabetes Complications. 2023;37:108514.
    >> Share

  107. RASTOGI A, Weir MR
    Multimodal efforts to slow the progression of chronic kidney disease in patients with type 2 diabetes mellitus.
    J Diabetes Complications. 2023;37:108515.
    >> Share

  108. DEROSA G, Rizzo M, Brunetti ND, Raddino R, et al
    ORal anticoaGulants in diAbetic and Nondiabetic patients with nOn-valvular atrial fibrillatioN (ORGANON).
    J Diabetes Complications. 2023;37:108512.
    >> Share

  109. IZADI R, Hejazi SH, Bahramikia S
    Injection of stem cells derived from allogeneic adipose tissue, a new strategy for the treatment of diabetic wounds.
    J Diabetes Complications. 2023;37:108496.
    >> Share

  110. SONG XT, Wei YL, Rui YF, Fan L, et al
    Echocardiographic evaluation of the effect of dapagliflozin on epicardial adipose tissue and left ventricular systolic function in type 2 diabetes mellitus.
    J Diabetes Complications. 2023;37:108509.
    >> Share

  111. MANICA D, Sandri G, da Silva GB, Manica A, et al
    Evaluation of the effects of metformin on antioxidant biomarkers and mineral levels in patients with type II diabetes mellitus: A cross-sectional study.
    J Diabetes Complications. 2023;37:108497.
    >> Share

  112. BAILEY RJ, Sarkar A, Snell-Bergeon JK, Burkhardt BR, et al
    Periodontitis and cardiovascular risk factors in subjects with and without type 1 diabetes: A cross sectional analysis.
    J Diabetes Complications. 2023;37:108494.
    >> Share

  113. VERDECIAS N, McQueen A, Von Nordheim DA, Broussard DJ Jr, et al
    Diabetes distress in a Medicaid sample: The role of psychosocial and health-related factors.
    J Diabetes Complications. 2023;37:108495.
    >> Share

  114. FORD JH, Lage MJ, Boye KS, Bae JP, et al
    Five-year morbidity and mortality rates in a U.S. population with obesity with and without prediabetes.
    J Diabetes Complications. 2023;37:108454.
    >> Share

  115. XIE Q, Ma L, Xiao Z, Yang M, et al
    Role of profilin-1 in vasculopathy induced by advanced glycation end products (AGEs).
    J Diabetes Complications. 2023;37:108415.
    >> Share

    April 2023
  116. TZOGIOU C, Wieser S, Eichler K, Carlander M, et al
    Incidence and costs of hypoglycemia in insulin-treated diabetes in Switzerland: A health-economic analysis.
    J Diabetes Complications. 2023;37:108476.
    >> Share

  117. LAURSEN JC, Hansen CS, Bordino M, Frimodt-Moller M, et al
    The association between blood oxygen saturation and baroreflex sensitivity in adults with type 1 diabetes with and without albuminuria.
    J Diabetes Complications. 2023;37:108473.
    >> Share

  118. XU J, Lv H
    PSTPIP2 alleviates obesity associated adipose tissue inflammation and insulin resistance in diabetes mice through promoting M2 macrophage polarization via activation of PPARgamma.
    J Diabetes Complications. 2023;37:108479.
    >> Share

  119. LI H, Li M, Dong S, Dong A, et al
    Preliminary study of the interactive effects of coronary heart disease and lacunar infarction on renal function in patients with type 2 diabetes mellitus by gender.
    J Diabetes Complications. 2023;37:108477.
    >> Share

  120. ZHANG C, Lin W, Xu Q, Li H, et al
    Association between high-density lipoprotein cholesterol to apolipoprotein A ratio and diabetic retinopathy: A cross-sectional study.
    J Diabetes Complications. 2023;37:108471.
    >> Share

  121. FARAH R, Alhajahjeh A, Nofal A, Hyasat TB, et al
    Clinical outcomes in patients with type 2 diabetes mellitus-related kidney disease: A Jordanian population cohort study.
    J Diabetes Complications. 2023;37:108478.
    >> Share

  122. RUAN Y, Mercuri L, Papadimitriou D, Galdikas A, et al
    Increase in hypoglycaemia and hyperglycaemia in people with diabetes admitted to hospital during COVID-19 pandemic.
    J Diabetes Complications. 2023;37:108474.
    >> Share

  123. CORBIN KD, Pittas AG, Desouza C, Grdinovac KK, et al
    Indices of hepatic steatosis and fibrosis in prediabetes and association with diabetes development in the vitamin D and type 2 diabetes study.
    J Diabetes Complications. 2023;37:108475.
    >> Share

  124. GULLAKSEN S, Vernstrom L, Sorensen SS, Funck KL, et al
    Effects of semaglutide and empagliflozin on oxygenation, vascular autoregulation, and central thickness of the retina in people with type 2 diabetes: A prespecified secondary analysis of a randomised clinical trial.
    J Diabetes Complications. 2023;37:108472.
    >> Share

  125. ADIE SK, Ketcham SW, Marshall VD, Farina N, et al
    The association of glucose control on in-hospital mortality in the cardiac intensive care unit.
    J Diabetes Complications. 2023;37:108453.
    >> Share

  126. LIN Y, Shao H, Fonseca V, Anderson AH, et al
    A prediction model on incident ESKD among individuals with T2D and CKD.
    J Diabetes Complications. 2023;37:108450.
    >> Share

  127. DESAI NR, Navaneethan SD, Nicholas SB, Pantalone KM, et al
    Design and rationale of FINE-REAL: A prospective study of finerenone in clinical practice.
    J Diabetes Complications. 2023;37:108411.
    >> Share

  128. BECHLIOULIS A, Markozannes G, Chionidi I, Liberopoulos E, et al
    The effect of SGLT2 inhibitors, GLP1 agonists, and their sequential combination on cardiometabolic parameters: A randomized, prospective, intervention study.
    J Diabetes Complications. 2023;37:108436.
    >> Share

    March 2023
  129. HAYASHI A, Shimizu N, Suzuki A, Fujishima R, et al
    Novel clinical associations between time in range and microangiopathies in people with type 2 diabetes mellitus on hemodialysis.
    J Diabetes Complications. 2023;37:108470.
    >> Share

  130. KATAOKA Y, Yasuda S, Asaumi Y, Honda S, et al
    Long-term effects of lowering postprandial glucose level on cardiovascular outcomes in early-stage diabetic patients with coronary artery disease: 10-year post-trial follow-up analysis of the DIANA study.
    J Diabetes Complications. 2023;37:108469.
    >> Share

  131. HU WS, Lin CL
    Patients with diabetes with and without sodium-glucose cotransporter-2 inhibitors use with incident cancer risk.
    J Diabetes Complications. 2023;37:108468.
    >> Share

  132. WOODHAMS LM, Chalmers L, Sim TF, Yeap BB, et al
    Efficacy and safety of sodium glucose cotransporter 2 inhibitors plus standard care in diabetic kidney disease: A systematic review and meta-analysis.
    J Diabetes Complications. 2023;37:108456.
    >> Share

  133. CIFUENTES-MENDIOLA SE, Solis-Suarez DL, Martinez-Davalos A, Garcia-Hernandez AL, et al
    Macrovascular and microvascular type 2 diabetes complications are interrelated in a mouse model.
    J Diabetes Complications. 2023;37:108455.
    >> Share

  134. MELING S, Tjora E, Eichele H, Nedergaard RB, et al
    The PanGut-study: Evoked potentials following rectal balloon distention, a way of evaluating diabetic autonomic neuropathy in the gut?
    J Diabetes Complications. 2023;37:108452.
    >> Share

  135. LIU W, Gao M, Yang S, Sun C, et al
    Effects of omega-3 supplementation on glucose and lipid metabolism in patients with gestational diabetes: A meta-analysis of randomized controlled trials.
    J Diabetes Complications. 2023;37:108451.
    >> Share

    February 2023
  136. GUO J, Jiang G, Chen J, Zhang M, et al
    Tumor tissue derived extracellular vesicles promote diabetic wound healing.
    J Diabetes Complications. 2023;37:108435.
    >> Share

  137. ROTBAIN CUROVIC V, Tofte N, Lindhardt M, Adamova K, et al
    Presence of retinopathy and incident kidney and cardiovascular events in type 2 diabetes with normoalbuminuria - A post-hoc analysis of the PRIORITY randomized clinical trial.
    J Diabetes Complications. 2023;37:108433.
    >> Share

  138. PANTALONE KM, Ji X, Kong SX, Elliott JC, et al
    Unmet needs and opportunities for optimal management of patients with type 2 diabetes and chronic kidney disease.
    J Diabetes Complications. 2023;37:108418.
    >> Share

  139. TESFAYE S, Brill S, Eerdekens M, Labrador MM, et al
    Diagnosis, management and impact of painful diabetic peripheral neuropathy: A patient survey in four European countries.
    J Diabetes Complications. 2023;37:108417.
    >> Share

  140. XIANG X, Huang X, Zhang Z, Gu J, et al
    Dysregulation of circulating CD4 + CXCR5 + PD-1+ T cells in diabetic retinopathy.
    J Diabetes Complications. 2023;37:108420.
    >> Share

  141. LIN Y, Shao H, Fonseca V, Anderson AH, et al
    A prediction model of CKD progression among individuals with type 2 diabetes in the United States.
    J Diabetes Complications. 2023;37:108413.
    >> Share

  142. VEKIC J, Stoian AP, Rizzo M
    Lipoprotein subclasses and early kidney dysfunction in young type 1 diabetes mellitus patients.
    J Diabetes Complications. 2023;37:108412.
    >> Share

  143. ZHANG Y, Zhang Q, Bai Y, Zheng H, et al
    Glycogen synthesis kinase-3beta involves in the analgesic effect of liraglutide on diabetic neuropathic pain.
    J Diabetes Complications. 2023;37:108416.
    >> Share

  144. ABO EL-ASRAR M, Ismail EAR, Elnhrawy AM, Thabet RA, et al
    Fatty acid binding protein 1 (FABP1) and fatty acid binding protein 2 (FABP2) as a link between diabetic nephropathy and subclinical atherosclerosis in children and adolescents with type 1 diabetes.
    J Diabetes Complications. 2023;37:108414.
    >> Share

  145. PEDROSA AR, Martins DC, Rizzo M, Silva-Nunes J, et al
    Metformin in SARS-CoV-2 infection: A hidden path - from altered inflammation to reduced mortality. A review from the literature.
    J Diabetes Complications. 2023;37:108391.
    >> Share

    January 2023
  146. BLANCHETTE V, Armstrong DG, Drudi L, Rizzo M, et al
    Upstream comprehensive management of individuals with diabetes with multimorbidity and frailty to act against amputation.
    J Diabetes Complications. 2023;37:108407.
    >> Share

  147. FENG B, Yang F, Liu J, Sun Q, et al
    Amelioration of diabetic kidney injury with dapagliflozin is associated with suppressing renal HMGB1 expression and restoring autophagy in obese mice.
    J Diabetes Complications. 2023;37:108409.
    >> Share

  148. CERIELLO A, Lalic N, Montanya E, Valensi P, et al
    NT-proBNP point-of-care measurement as a screening tool for heart failure and CVD risk in type 2 diabetes with hypertension.
    J Diabetes Complications. 2023;37:108410.
    >> Share

  149. WIRKKALA J, Kubin AM, Ohtonen P, Falck A, et al
    Outcomes of 35-year duration of type 1 diabetes and proliferative diabetic retinopathy on functional vision and quality of life: Benefits of good glycemic control.
    J Diabetes Complications. 2023;37:108408.
    >> Share

  150. CHEN Y, Wang Y, Zhang Y, Li M, et al
    Association of peripheral neuropathy with subclinical left ventricular dysfunction in patients with type 2 diabetes.
    J Diabetes Complications. 2023;37:108406.
    >> Share

  151. LUNDHOLM MD, Bena J, Zhou K, Tsushima Y, et al
    Prevalence and clinical determinants of non-alcoholic fatty liver disease by liver scores in adults with type 1 diabetes.
    J Diabetes Complications. 2023;37:108405.
    >> Share

  152. BORDERIE G, Foussard N, Larroumet A, Blanco L, et al
    Albuminuric diabetic kidney disease predicts foot ulcers in type 2 diabetes.
    J Diabetes Complications. 2023;37:108403.
    >> Share

  153. HANDELSMAN Y, Butler J, Bakris GL, DeFronzo RA, et al
    Early intervention and intensive management of patients with diabetes, cardiorenal, and metabolic diseases.
    J Diabetes Complications. 2023;37:108389.
    >> Share

  154. PORADZKA AA, Czupryniak L
    The use of the artificial neural network for three-month prognosis in diabetic foot syndrome.
    J Diabetes Complications. 2023;37:108392.
    >> Share

  155. PINTO C, Sa JR, Lana J, Dualib P, et al
    Association of parental cardiovascular risk factors with offspring type 1 diabetes mellitus insulin sensitivity.
    J Diabetes Complications. 2023;37:108393.
    >> Share

    December 2022
  156. LIARAKOS AL, Tentolouris A, Kokkinos A, Eleftheriadou I, et al
    Impact of Glucagon-like peptide 1 receptor agonists on peripheral arterial disease in people with diabetes mellitus: A narrative review.
    J Diabetes Complications. 2022;37:108390.
    >> Share

  157. ASLANI S, Jensen CW, Olsson AO, Thomsen SS, et al
    Time in range is associated with less hypoglycemia fear and higher diabetes technology acceptance in adults with well-controlled T1D.
    J Diabetes Complications. 2022;37:108388.
    >> Share

  158. BARRERA ECHEGOYEN FX, Szeto A, Mendez AJ, Garg R, et al
    The nature and characteristics of hypertriglyceridemia in a large cohort with type 2 diabetes.
    J Diabetes Complications. 2022;37:108387.
    >> Share

  159. ORIOT P, Hermans MP
    Intermittent-scanned continuous glucose monitoring with low glucose alarms decreases hypoglycemia incidence in middle-aged adults with type 1 diabetes in real-life setting.
    J Diabetes Complications. 2022;37:108385.
    >> Share

  160. TORM MEW, Dorweiler TF, Fickweiler W, Levine SR, et al
    Frontiers in diabetic retinal disease.
    J Diabetes Complications. 2022;37:108386.
    >> Share

  161. WANG A, Zhang S, Li Y, Zhu F, et al
    Study on the relationship between lipoprotein (a) and diabetic kidney disease.
    J Diabetes Complications. 2022;37:108378.
    >> Share

  162. PAULEY ME, Vinovskis C, MacDonald A, Baca M, et al
    Triglyceride content of lipoprotein subclasses and kidney hemodynamic function and injury in adolescents with type 1 diabetes.
    J Diabetes Complications. 2022;37:108384.
    >> Share

  163. XIA C, Suriyanarayanan S, Gong Y, Fridman V, et al
    Long-term effects of l-serine supplementation upon a mouse model of diabetic neuropathy.
    J Diabetes Complications. 2022;37:108383.
    >> Share

  164. LI X, Kong X, Li R
    Correlation between lipoprotein(a), albuminuria, myostatin and sarcopenia in elderly patients with type 2 diabetes.
    J Diabetes Complications. 2022;37:108382.
    >> Share

  165. VUORLAAKSO M, Kiiski J, Majava M, Helminen M, et al
    Retrospective cohort study of long-term outcomes and prognostic factors for survival after lower extremity amputation in patients with diabetes.
    J Diabetes Complications. 2022;37:108377.
    >> Share

  166. LI H, Zhang J, Guo Q, Xie W, et al
    Associations among carotid plaque progression, cerebrovascular/cardiovascular diseases and LDL-C/non-HDL-C goal achievement in diabetic patients: A retrospective cohort study.
    J Diabetes Complications. 2022;37:108381.
    >> Share

  167. ALEXOPOULOS AS, Soliman D, Lewinski AA, Strawbridge E, et al
    Simplifying therapy to assure glycemic control and engagement (STAGE) in poorly-controlled diabetes: A pilot study.
    J Diabetes Complications. 2022;37:108364.
    >> Share

  168. XU Y, Hou H, Zhao L
    The role of VCAM-1 in diabetic retinopathy: A systematic review and meta-analysis.
    J Diabetes Complications. 2022;37:108380.
    >> Share

  169. KANIA M, Sudul P, Mazur K, Chaykivska Z, et al
    Type 1 diabetes outpatient care and treatment effectiveness during COVID-19: A single-center cohort study.
    J Diabetes Complications. 2022;37:108379.
    >> Share

  170. TALL BULL S, Nuffer W, Trujillo JM
    Tirzepatide: A novel, first-in-class, dual GIP/GLP-1 receptor agonist.
    J Diabetes Complications. 2022;36:108332.
    >> Share

    November 2022
  171. GONG M, Xu M, Meng J, Jiang S, et al
    Diabetic microvascular complications are associated with left atrial structural alterations in asymptomatic type 2 diabetes patients: A cross-sectional study.
    J Diabetes Complications. 2022;37:108361.
    >> Share

  172. DOTZERT MS, McDonald MW, Olver TD, Sammut MJ, et al
    The influence of exercise training versus intensive insulin therapy on insulin resistance development in type 1 diabetes.
    J Diabetes Complications. 2022;37:108365.
    >> Share

  173. LI J, Ji C, Zhang W, Lan L, et al
    Effect of new glucose-lowering drugs on stroke in patients with type 2 diabetes: A systematic review and Meta-analysis.
    J Diabetes Complications. 2022;37:108362.
    >> Share

  174. PAPACHRISTOFOROU E, Liatis S, Psoma O, Kountouri A, et al
    Effect of the first and second COVID-19 associated lockdown on the metabolic control of patients with type 2 diabetes in Greece.
    J Diabetes Complications. 2022;37:108363.
    >> Share

  175. MUZUROVIC E, Rizzo M, Mikhailidis DP
    Obesity and nonalcoholic fatty liver disease in type 1 diabetes mellitus patients.
    J Diabetes Complications. 2022;36:108359.
    >> Share

  176. ZHENG X, Jiang M, Ren X, Han L, et al
    The longitudinal association of remnant cholesterol with diabetes in middle-aged and elderly Chinese: A nationwide population-based cohort study.
    J Diabetes Complications. 2022;37:108360.
    >> Share

  177. LIMONTE CP, Kretzler M, Pennathur S, Pop-Busui R, et al
    Present and future directions in diabetic kidney disease.
    J Diabetes Complications. 2022;36:108357.
    >> Share

  178. DEMIRER B, Yardimci H, Erem Basmaz S
    Inflammation level in type 2 diabetes is associated with dietary advanced glycation end products, Mediterranean diet adherence and oxidative balance score: A pathway analysis.
    J Diabetes Complications. 2022;37:108354.
    >> Share

  179. OLESEN K, Willaing I, Maindal HT, Andersen GS, et al
    Does health literacy predict cardiometabolic marker trajectories among people with diabetes? A longitudinal mixed-effect analysis.
    J Diabetes Complications. 2022;37:108358.
    >> Share

  180. PAPACHRISTOU S, Pafili K, Trypsianis G, Papazoglou D, et al
    Skin advanced glycation end products as a screening tool of neuropathy in type 2 diabetes mellitus.
    J Diabetes Complications. 2022;36:108356.
    >> Share

  181. CLEMENTS JM
    Access to care by Medicare beneficiaries in the U.S. with diabetes and multiple chronic conditions during the COVID-19 pandemic.
    J Diabetes Complications. 2022;36:108355.
    >> Share

  182. MIZRAK HI, Hansen TW, Andersen JA, Rossing P, et al
    Distal symmetrical polyneuropathy is present in all individuals with diabetes and foot ulcers - and does not associate with healing time.
    J Diabetes Complications. 2022;36:108353.
    >> Share

  183. WU J, Zhao X, Chen H, Zhu S, et al
    Metabolic effects of the dual SGLT 1/2 inhibitor sotagliflozin on blood pressure and body weight reduction in people with diabetes: An updated meta-analysis of randomized controlled trials.
    J Diabetes Complications. 2022;36:108352.
    >> Share

  184. VINODHINI S, Sengani M, Choudhury AA, Ramasubbu K, et al
    Regulation of glucose transporter-4 intervention with S. saman leaves extract in streptozotocin-induced diabetic rats.
    J Diabetes Complications. 2022;36:108340.
    >> Share

  185. JENSTERLE M, Rizzo M, Janez A
    Weight response to GLP-1 receptor agonists: Why women do it better?
    J Diabetes Complications. 2022;36:108310.
    >> Share

    October 2022
  186. TAS E, Bai S, Mak D, Diaz EC, et al
    Obesity, but not glycemic control, predicts liver steatosis in children with type 1 diabetes.
    J Diabetes Complications. 2022;36:108341.
    >> Share

  187. LUTSKI M, Weinstein G, Goldbourt U, Tanne D, et al
    Peripheral sensory nerve function, type 2 diabetes and frailty among men with cardiovascular disease.
    J Diabetes Complications. 2022;36:108337.
    >> Share

  188. TAN SW, Xie T, Malik TH, Gao Y, et al
    Advances of neurovascular protective potential of 3-N-butylphthalide and its derivatives in diabetic related diseases.
    J Diabetes Complications. 2022;36:108335.
    >> Share

  189. POPOVIC DS, Stoian AP, Papanas N
    Could cardiorenal benefits of sodium-glucose co-transporter 2 inhibitors be extended to type 1 diabetes mellitus?
    J Diabetes Complications. 2022;36:108338.
    >> Share

  190. ANG L, Mizokami-Stout K, Eid SA, Elafros M, et al
    The conundrum of diabetic neuropathies-Past, present, and future.
    J Diabetes Complications. 2022;36:108334.
    >> Share

  191. RIZVI AA, Kathuria A, Al Mahmeed W, Al-Rasadi K, et al
    Post-COVID syndrome, inflammation, and diabetes.
    J Diabetes Complications. 2022;36:108336.
    >> Share

  192. SU EJ, Lawrence DA
    Diabetes and the treatment of ischemic stroke.
    J Diabetes Complications. 2022;36:108318.
    >> Share

  193. SAVELIEFF MG, Chen KS, Elzinga SE, Feldman EL, et al
    Diabetes and dementia: Clinical perspective, innovation, knowledge gaps.
    J Diabetes Complications. 2022;36:108333.
    >> Share

  194. SHAO H, Shi L, Lin Y, Fonseca V, et al
    Using modern risk engines and machine learning/artificial intelligence to predict diabetes complications: A focus on the BRAVO model.
    J Diabetes Complications. 2022;36:108316.
    >> Share

    September 2022
  195. SCHMIDT BM, Holmes CM, Najarian K, Gallagher K, et al
    On diabetic foot ulcer knowledge gaps, innovation, evaluation, prediction markers, and clinical needs.
    J Diabetes Complications. 2022;36:108317.
    >> Share

  196. LYTVYN Y, Albakr R, Bjornstad P, Lovblom LE, et al
    Renal hemodynamic dysfunction and neuropathy in longstanding type 1 diabetes: Results from the Canadian study of longevity in type 1 diabetes.
    J Diabetes Complications. 2022;36:108320.
    >> Share

  197. GAO Y, Zhou M, Xu X, Chen WY, et al
    Effects of flash glucose monitoring on glycemic control in participants with diabetes mellitus: A meta-analysis of randomized controlled trials.
    J Diabetes Complications. 2022;36:108314.
    >> Share

  198. SAITO I, Maruyama K, Kato T, Takata Y, et al
    Role of insulin resistance in the association between resting heart rate and type 2 diabetes: A prospective study.
    J Diabetes Complications. 2022;36:108319.
    >> Share

  199. IIDA T, Hosojima M, Kabasawa H, Yamamoto-Kabasawa K, et al
    Urinary A- and C-megalin predict progression of diabetic kidney disease: an exploratory retrospective cohort study.
    J Diabetes Complications. 2022;36:108312.
    >> Share

  200. IQBAL A, Tekin Z, Kattan MW, Ji X, et al
    Association between first-line monotherapy with metformin and the risk of atrial fibrillation (AMRAF) in patients with type 2 diabetes.
    J Diabetes Complications. 2022;36:108315.
    >> Share

  201. YANG H, Xia M, Liu Z, Xing Y, et al
    Nomogram for prediction of diabetic retinopathy in patients with type 2 diabetes mellitus: A retrospective study.
    J Diabetes Complications. 2022;36:108313.
    >> Share

  202. SAEI GHARE NAZ M, Sheidaei A, Azizi F, Ramezani Tehrani F, et al
    Gestational diabetes mellitus and hypertensive disorder of pregnancy play as spouse-pair risk factors of diabetes and hypertension: Insights from Tehran Lipid and Glucose Study.
    J Diabetes Complications. 2022;36:108311.
    >> Share

  203. TINSLEY JP, Carpenter RD, Pyle LL, Snell-Bergeon JK, et al
    Femoral neck structural properties are altered in adults with type 1 diabetes.
    J Diabetes Complications. 2022;36:108308.
    >> Share

  204. SHAIKH K, Ahmed A, Gransar H, Lee J, et al
    Extent of subclinical atherosclerosis on coronary computed tomography and impact of statins in patients with diabetes without known coronary artery disease: Results from CONFIRM registry.
    J Diabetes Complications. 2022;36:108309.
    >> Share

  205. CHIANG HH, Surampudi P, Sood A
    Determinants of initial insulin therapy for hospitalized patients with diabetes mellitus.
    J Diabetes Complications. 2022;36:108307.
    >> Share

  206. KHAN SA, Shields S, Abusamaan MS, Mathioudakis N, et al
    Association between dysglycemia and the Charlson Comorbidity Index among hospitalized patients with diabetes.
    J Diabetes Complications. 2022;36:108305.
    >> Share

  207. LIAO KM, Wang SH, Tsai LT, Chen YC, et al
    A non-invasive harmonic analysis to assess risk of retinopathy in type 2 diabetes mellitus.
    J Diabetes Complications. 2022;36:108306.
    >> Share

  208. CHIKOTI S, Najiya U, Sumanlatha G, Jahan P, et al
    Cytokine gene variants of TNF-alpha and IL-10 in the propensity of type 2 diabetes in south Indian population.
    J Diabetes Complications. 2022;36:108304.
    >> Share

    August 2022
  209. ZHANG Y, Yin Y, Zhang X, Ye J, et al
    Association of adverse childhood experiences with diabetes: A systematic review and meta-analysis.
    J Diabetes Complications. 2022;36:108289.
    >> Share

  210. VERHAGEN C, Janssen J, Minderhoud CA, van den Berg E, et al
    Chronic kidney disease and cognitive decline in patients with type 2 diabetes at elevated cardiovascular risk.
    J Diabetes Complications. 2022;36:108303.
    >> Share

  211. BLAIR Y, Wessells H, Pop-Busui R, Ang L, et al
    Urologic complications in diabetes.
    J Diabetes Complications. 2022;36:108288.
    >> Share

  212. KIANMEHR H, Guo J, Lin Y, Luo J, et al
    A machine learning approach identifies modulators of heart failure hospitalization prevention among patients with type 2 diabetes: A revisit to the ACCORD trial.
    J Diabetes Complications. 2022;36:108287.
    >> Share

  213. PAPPA E, Kostara C, Bairaktari E, Arvaniti E, et al
    Effect of fixed-dose combination of insulin degludec and liraglutide on apoB-containing lipoprotein subclasses and HDL lipidome in type 2 diabetes.
    J Diabetes Complications. 2022;36:108286.
    >> Share

  214. GOLDENBERG RM
    Progression of retinopathy with glucagon-like peptide-1 receptor agonists with cardiovascular benefits in type 2 diabetes - A systematic review and meta-analysis.
    J Diabetes Complications. 2022;36:108285.
    >> Share

  215. MAHGOUB U, Magee MJ, Heydari M, Choudhary M, et al
    Outpatient clinic attendance and outcomes among patients hospitalized with diabetic foot ulcers.
    J Diabetes Complications. 2022;36:108283.
    >> Share

  216. CUI Y, Marshall A, Tsaih SW, Palatnik A, et al
    Impact of prior gestational diabetes on long-term type 2 diabetes complications.
    J Diabetes Complications. 2022;36:108282.
    >> Share

  217. DESOUZA C, Chatterjee R, Vickery EM, Nelson J, et al
    The effect of vitamin D supplementation on cardiovascular risk in patients with prediabetes: A secondary analysis of the D2d study.
    J Diabetes Complications. 2022;36:108230.
    >> Share

    July 2022
  218. HJORTKJAER HO, Persson F, Theilade S, Winther SA, et al
    Non-dipping and higher nocturnal blood pressure are associated with risk of mortality and development of kidney disease in type 1 diabetes.
    J Diabetes Complications. 2022;36:108270.
    >> Share

  219. AL-KINDI S, Dong T, Chen W, Tashtish N, et al
    Relation of coronary calcium scoring with cardiovascular events in patients with diabetes: The CLARIFY Registry.
    J Diabetes Complications. 2022;36:108269.
    >> Share

  220. ESPELAND MA, Howard M, Bennett W, Robusto BA, et al
    Associations between cognitive function and endogenous levels of estradiol and testosterone in adults with type 2 diabetes.
    J Diabetes Complications. 2022;36:108268.
    >> Share

  221. LEVITSKY LL, Drews KL, Haymond M, Glubitosi-Klug RA, et al
    The obesity paradox: Retinopathy, obesity, and circulating risk markers in youth with type 2 diabetes in the TODAY Study.
    J Diabetes Complications. 2022;36:108259.
    >> Share

  222. LOW S, Goh KS, Ng TP, Moh A, et al
    Decline in skeletal muscle mass is associated with cognitive decline in type 2 diabetes mellitus.
    J Diabetes Complications. 2022;36:108258.
    >> Share

  223. TIAN L, Yang YM, Zhu J, Zhang H, et al
    Gender difference in association between diabetes mellitus and all-cause mortality in atrial fibrillation patients.
    J Diabetes Complications. 2022;36:108265.
    >> Share

  224. MUTHULINGAM JA, Brock C, Hansen TM, Drewes AM, et al
    Disrupted white matter integrity in the brain of type 1 diabetes is associated with peripheral neuropathy and abnormal brain metabolites.
    J Diabetes Complications. 2022;36:108267.
    >> Share

  225. WIUM-ANDERSEN IK, Jorgensen TSH, Jorgensen MB, Osler M, et al
    Diabetes, sleep disorders and risk of depression - A Danish register-based cohort study.
    J Diabetes Complications. 2022;36:108266.
    >> Share

  226. LIN KD, Chang LH, Wu YR, Hsu WH, et al
    Association of depression and parasympathetic activation with glycemic control in type 2 diabetes mellitus.
    J Diabetes Complications. 2022 Jul 12:108264.
    >> Share

  227. MARK EB, Liao D, Nedergaard RB, Hansen TM, et al
    Central neuronal transmission in response to tonic cold pain is modulated in people with type 1 diabetes and severe polyneuropathy.
    J Diabetes Complications. 2022 Jul 12:108263.
    >> Share

  228. GRASSI BA, Carames B, Plaza-Plaza JC, Onetto MT, et al
    Insulin settings and their association with time in range in patients with type 1 diabetes users of predictive low glucose suspend (PLGS) augmented insulin pumps in Santiago, Chile.
    J Diabetes Complications. 2022 Jul 11:108262.
    >> Share

  229. HEUBEL AD, Kabbach EZ, Migliato GR, Russo MIS, et al
    Role of arterial stiffness and endothelial dysfunction on lower limb performance in older adults with type 2 diabetes: A cross-sectional study.
    J Diabetes Complications. 2022 Jul 10:108260.
    >> Share

  230. STOUGAARD EB, Rossing P, Cherney D, Vistisen D, et al
    Sodium-glucose cotransporter 2 inhibitors as adjunct therapy for type 1 diabetes and the benefit on cardiovascular and renal disease evaluated by Steno risk engines.
    J Diabetes Complications. 2022 Jul 9:108257. doi: 10.1016/j.jdiacomp.2022.108257
    >> Share

  231. YOSHIDA Y, Joshi P, Barri S, Wang J, et al
    Progression of retinopathy with glucagon-like peptide-1 receptor agonists with cardiovascular benefits in type 2 diabetes - A systematic review and meta-analysis.
    J Diabetes Complications. 2022 Jul 5:108255. doi: 10.1016/j.jdiacomp.2022.108255
    >> Share

  232. FISHER L, Polonsky WH, Perez-Nieves M, Desai U, et al
    A new perspective on diabetes distress using the type 2 diabetes distress assessment system (T2-DDAS): Prevalence and change over time.
    J Diabetes Complications. 2022 Jul 5:108256. doi: 10.1016/j.jdiacomp.2022.108256
    >> Share

  233. BARZILAY JI, Younes N, Pop-Busui R, Florez H, et al
    Corrigendum to "The cross-sectional association of renal dysfunction with tests of cognition in middle-aged adults with early type 2 diabetes The GRADE Study" [J. Diabetes Complicat., 35 (3) (2021) 107805].
    J Diabetes Complications. 2022 Jul 5:108254. doi: 10.1016/j.jdiacomp.2022.108254
    >> Share

  234. CHOI D, Gujral UP, Patel SA
    Mortality differentials by previous diagnosis of diabetes and glycemic status in the United States.
    J Diabetes Complications. 2022;36:108250.
    >> Share

  235. HEMPE JM, Hsia DS
    Variation in the hemoglobin glycation index.
    J Diabetes Complications. 2022;36:108223.
    >> Share

    June 2022
  236. KANAZAWA K, Suzuki S, Koga S, Kuwabara K, et al
    A comprehensive risk assessment for nocturnal hypoglycemia in geriatric patients with type 2 diabetes: A single-center case-control study.
    J Diabetes Complications. 2022 Jun 28:108239.
    >> Share

  237. DE LOS A JIMENEZ PRIETO P, Alvarez Banuelos MT, Romero JM, Cordoba BC, et al
    Influence of type 2 diabetes mellitus on mortality in women with breast cancer: A matched case-control study.
    J Diabetes Complications. 2022 Jun 28:108249.
    >> Share

  238. SOW MA, Magne J, Salle L, Nobecourt E, et al
    Prevalence, determinants and prognostic value of high coronary artery calcium score in asymptomatic patients with diabetes: A systematic review and meta-analysis.
    J Diabetes Complications. 2022 Jun 26:108237.
    >> Share

  239. HU B, Zhang L, Zhao ZS, Qi YC, et al
    The predictive value of Thromboelastography (TEG) parameters in vascular complications in patients with type 2 diabetes mellitus.
    J Diabetes Complications. 2022 Jun 24:108236.
    >> Share

  240. WU Y, Liu F
    Aspartate aminotransferase to alanine aminotransferase ratio and the risk of diabetic nephropathy progression in patients with type 2 diabetes mellitus: A biopsy-based study.
    J Diabetes Complications. 2022 Jun 24:108235.
    >> Share

  241. GUO J, Costacou T, Orchard TJ
    Long term risk of heart failure in individuals with childhood-onset type 1 diabetes.
    J Diabetes Complications. 2022 Jun 21:108233.
    >> Share

  242. RIGALLEAU V, Larroumet A, Ducos C, Rigo M, et al
    Cardiovascular events after a dramatic reduction of HbA1c in hospitalized subjects with type 2 diabetes and high long-term glucose exposure.
    J Diabetes Complications. 2022 Jun 21:108234.
    >> Share

  243. CHATWIN H, Broadley M, Hendrieckx C, Carlton J, et al
    The impact of hypoglycaemia on quality of life among adults with type 1 diabetes: Results from "YourSAY: Hypoglycaemia".
    J Diabetes Complications. 2022 Jun 21:108232.
    >> Share

  244. WUKICH DK, Raspovic KM, Jupiter DC, Heineman N, et al
    Amputation and infection are the greatest fears in patients with diabetes foot complications.
    J Diabetes Complications. 2022 Jun 10:108222.
    >> Share

  245. HANDELSMAN Y, Bunch TJ, Rodbard HW, Steinberg BA, et al
    Impact of dronedarone on patients with atrial fibrillation and diabetes: A sub-analysis of the ATHENA and EURIDIS/ADONIS studies.
    J Diabetes Complications. 2022 Jun 8:108227. doi: 10.1016/j.jdiacomp.2022.108227
    >> Share

  246. ALAQEEL A, Gomez R, Chalew SA
    Glucose-independent racial disparity in HbA1c is evident at onset of type 1 diabetes.
    J Diabetes Complications. 2022 Jun 8:108229. doi: 10.1016/j.jdiacomp.2022.108229
    >> Share

  247. GUNDOGDU KO, Dogan E, Celik E, Alagoz G, et al
    Effect of intravitreal ranibizumab on serous retinal detachment in diabetic macular edema.
    J Diabetes Complications. 2022 Jun 7:108228. doi: 10.1016/j.jdiacomp.2022.108228
    >> Share

  248. KIBURG KV, Galligan A, Sundararajan V, MacIsaac RJ, et al
    Temporal trends in non-traumatic lower extremity amputations (LEAs) and their association with 12-month mortality in people with diabetes, 2004-2016.
    J Diabetes Complications. 2022 Jun 3:108221. doi: 10.1016/j.jdiacomp.2022.108221
    >> Share

  249. SHIMIZU N, Ogawa A, Hayashi A, Shichiri M, et al
    Discordance in the reduction rate between glycated albumin and glycated hemoglobin levels in type 2 diabetes patients receiving SGLT2 inhibitors.
    J Diabetes Complications. 2022 Jun 2:108225. doi: 10.1016/j.jdiacomp.2022.108225
    >> Share

  250. MIKOLASEVIC I, Domislovic V, Ruzic A, Hauser G, et al
    Elastographic parameters of liver steatosis and fibrosis predict independently the risk of incident chronic kidney disease and acute myocardial infarction in patients with type 2 diabetes mellitus.
    J Diabetes Complications. 2022 Jun 2:108226. doi: 10.1016/j.jdiacomp.2022.108226
    >> Share

  251. AL-KINDI SG, Janus SE, Neeland IJ, Rajagopalan S, et al
    Contemporary utilization of GLP1 receptor agonists and SGLT2 inhibitors in patients with diagnosed type 2 diabetes and cardiovascular disease in the United States.
    J Diabetes Complications. 2022 Jun 1:108224. doi: 10.1016/j.jdiacomp.2022.108224
    >> Share

    May 2022
  252. JOINER KL, McEwen LN, Hurst TE, Adams MP, et al
    Domains from the health belief model predict enrollment in the National Diabetes Prevention Program among insured adults with prediabetes.
    J Diabetes Complications. 2022 May 17:108220.
    >> Share

  253. ANG SF, Low SKM, Ng TP, Ang K, et al
    Association of early-onset Type 2 diabetes with cognitive impairment is partially mediated by increased pulse pressure.
    J Diabetes Complications. 2022 May 13:108209.
    >> Share

  254. UDDIN J, Zhu S, Malla G, Levitan EB, et al
    Trends in diagnosed hypertension prevalence by geographic region for older adults with and without diagnosed diabetes, 2005-2017.
    J Diabetes Complications. 2022 May 9:108208. doi: 10.1016/j.jdiacomp.2022.108208
    >> Share

  255. WENTZELL K, Volkening L, Laffel L
    Concordance and discordance between youth and their parents' reports of diabetes distress: The importance of youth perceptions.
    J Diabetes Complications. 2022 May 2:108207. doi: 10.1016/j.jdiacomp.2022.108207
    >> Share

  256. SHAPIRA A, Kane NS, Tanenbaum ML, Hoogendoorn CJ, et al
    Memory complaints moderate the concordance between self-report and electronically monitored adherence in adults with type 2 diabetes.
    J Diabetes Complications. 2022 May 2:108205. doi: 10.1016/j.jdiacomp.2022.108205
    >> Share

    April 2022
  257. LIMONTE CP, Hall YN, Trikudanathan S, Tuttle KR, et al
    Prevalence of SGLT2i and GLP1RA use among US adults with type 2 diabetes.
    J Diabetes Complications. 2022 Apr 30:108204.
    >> Share

  258. MELENA I, Piani F, Tommerdahl KL, Severn C, et al
    Aminoaciduria and metabolic dysregulation during diabetic ketoacidosis: Results from the diabetic kidney alarm (DKA) study.
    J Diabetes Complications. 2022 Apr 28:108203.
    >> Share

  259. SKRHA J JR, Horova E, Soupal J, Valerianova A, et al
    Skin autofluorescence corresponds to microvascular reactivity in diabetes mellitus.
    J Diabetes Complications. 2022 Apr 28:108206.
    >> Share

  260. CHEN Y, Peng L, He J, Wu J, et al
    Impact of hepatitis B virus infection on maternal and infant outcomes of women with gestational diabetes mellitus: A three-year retrospective study.
    J Diabetes Complications. 2022 Apr 20:108201.
    >> Share

  261. OSSAI CI, Wickramasinghe N
    A hybrid approach for risk stratification and predictive modelling of 30-days unplanned readmission of comorbid patients with diabetes.
    J Diabetes Complications. 2022 Apr 20:108200.
    >> Share

    March 2022
  262. PUNNOSE J, Malhotra RK, Sukhija K, Rijhwani RM, et al
    Is HbA1c in the first trimester associated with adverse outcomes among pregnant Asian Indian women without gestational diabetes?
    J Diabetes Complications. 2022 Mar 31:108187.
    >> Share

  263. LOGANATHAN J, Cohen AC, Kaloupis GM, Harris C, et al
    A pilot clinical study to Evaluate Liraglutide-mediated Anti-platelet activity in patients with type-2 Diabetes (ELAID study).
    J Diabetes Complications. 2022 Mar 30:108188.
    >> Share

  264. HUIFEN Z, Yaping X, Meijing Z, Huibin H, et al
    Effects of moderate-intensity resistance exercise on blood glucose and pregnancy outcome in patients with gestational diabetes mellitus: A randomized controlled trial.
    J Diabetes Complications. 2022 Mar 29:108186.
    >> Share

  265. VLACHOU E, Ntikoudi A, Owens DA, Nikolakopoulou M, et al
    Effectiveness of cognitive behavioral therapy-based interventions on psychological symptoms in adults with type 2 diabetes mellitus: An update review of randomized controlled trials.
    J Diabetes Complications. 2022 Mar 26:108185.
    >> Share

  266. WIUM-ANDERSEN MK, Jorgensen TSH, Jorgensen MB, Rungby J, et al
    The association between birth weight, ponderal index, psychotropic medication, and type 2 diabetes in individuals with severe mental illness.
    J Diabetes Complications. 2022 Mar 24:108181.
    >> Share

  267. HOOGENDOORN CJ, Qin J, Wang C, Roque N, et al
    Depressive symptoms mediate the relationship between diabetes and cognitive performance in a community-based sample of older adults.
    J Diabetes Complications. 2022 Mar 23:108183.
    >> Share

  268. SARRAY S, Lamine LB, Dallel M, Jairajpuri D, et al
    Association of MMP-2 genes variants with diabetic retinopathy in Tunisian population with type 2 diabetes.
    J Diabetes Complications. 2022 Mar 18:108182.
    >> Share

  269. YE W, Ding X, Putnam N, Farej R, et al
    Development of clinical prediction models for renal and cardiovascular outcomes and mortality in patients with type 2 diabetes and chronic kidney disease using time-varying predictors.
    J Diabetes Complications. 2022 Mar 17:108180.
    >> Share

  270. IDIAQUEZ RIOS JF, Lovblom LE, Perkins BA, Bril V, et al
    Orthostatic blood pressure changes and diabetes duration.
    J Diabetes Complications. 2022 Mar 15:108169.
    >> Share

  271. REN Y, Zhu W, Shi J, Shao A, et al
    Association between KCNJ11 E23K polymorphism and the risk of type 2 diabetes mellitus: A global meta-analysis.
    J Diabetes Complications. 2022 Mar 11:108170.
    >> Share

  272. CHUANCHAIYAKUL N, Thongtang N, Rattanaumpawan P
    Cumulative incidence of and risk factors for herpes zoster among patients with diabetes mellitus: Results from a 10-year nested case-control study.
    J Diabetes Complications. 2022 Mar 8:108168. doi: 10.1016/j.jdiacomp.2022.108168
    >> Share

  273. SONG XT, Wang SK, Zhang PY, Fan L, et al
    Association between epicardial adipose tissue and left ventricular function in type 2 diabetes mellitus: Assessment using two-dimensional speckle tracking echocardiography.
    J Diabetes Complications. 2022 Mar 4:108167. doi: 10.1016/j.jdiacomp.2022.108167
    >> Share

  274. TONG HF, Lee HH, Tong TT, Lam SF, et al
    Neurological manifestations in m.3243A>G-related disease triggered by metformin.
    J Diabetes Complications. 2022;36:108111.
    >> Share

    February 2022
  275. VAN BAAR MJB, van Bommel EJM, Smits MM, Touw DJ, et al
    Whole-body insulin clearance in people with type 2 diabetes and normal kidney function: Relationship with glomerular filtration rate, renal plasma flow, and insulin sensitivity.
    J Diabetes Complications. 2022 Feb 20:108166.
    >> Share

  276. KARJEE H, Ghosh S, Dhibar T
    Association of mid-life cerebral small vessel disease with diabetic retinopathy in type 2 diabetes in an Indian population.
    J Diabetes Complications. 2022 Feb 11:108149.
    >> Share

  277. SIWAN E, Twigg SM, Min D
    Alterations of CD163 expression in the complications of diabetes: A systematic review.
    J Diabetes Complications. 2022 Feb 9:108150. doi: 10.1016/j.jdiacomp.2022.108150
    >> Share

  278. GABA R, Balasubramanyam A
    Covid-19: A new cause of "provoked" A-beta+ Ketosis-Prone Diabetes.
    J Diabetes Complications. 2022 Feb 7:108147. doi: 10.1016/j.jdiacomp.2022.108147
    >> Share

  279. MIZOKAMI-STOUT K, Bailey R, Ang L, Aleppo G, et al
    Symptomatic diabetic autonomic neuropathy in type 1 diabetes (T1D): Findings from the T1D exchange.
    J Diabetes Complications. 2022 Feb 7:108148. doi: 10.1016/j.jdiacomp.2022.108148
    >> Share

  280. KOCHER T, Holtfreter B, Nauck MA
    Comment: Type 1 diabetes and oral health: Findings from the Epidemiology of Diabetes Interventions and Complications (EDIC) study.
    J Diabetes Complications. 2022 Feb 5:108146. doi: 10.1016/j.jdiacomp.2022.108146
    >> Share

  281. ABDELHAFIZ AH, Sinclair AJ
    Metabolic phenotypes explain the relationship between dysglycaemia and frailty in older people with type 2 diabetes.
    J Diabetes Complications. 2022 Feb 4:108144. doi: 10.1016/j.jdiacomp.2022.108144
    >> Share

  282. CROMER SJ, Colling C, Schatoff D, Leary M, et al
    Newly diagnosed diabetes vs. pre-existing diabetes upon admission for COVID-19: Associated factors, short-term outcomes, and long-term glycemic phenotypes.
    J Diabetes Complications. 2022 Feb 4:108145. doi: 10.1016/j.jdiacomp.2022.108145
    >> Share

  283. RASH CJ, Alessi SM, Foster N, Tamborlane W, et al
    Tobacco use patterns and clinical outcomes in the T1D exchange.
    J Diabetes Complications. 2022;36:108128.
    >> Share

    January 2022
  284. LEWIS EJH, Lovblom LE, Lanctot S, Scarr D, et al
    The association between physical activity time and neuropathy in longstanding type 1 diabetes: A cross-sectional analysis of the Canadian study of longevity in type 1 diabetes.
    J Diabetes Complications. 2022 Jan 31:108134.
    >> Share

  285. SHAO H, Kianmehr H, Guo J, Li P, et al
    Efficacy of iGlarLixi on 5-year risk of diabetes-related complications: A simulation study.
    J Diabetes Complications. 2022 Jan 25:108132.
    >> Share

  286. RAJALAKSHMI R, UmaSankari G, Sivaprasad S, Venkatesan U, et al
    Prevalence and risk factors for diabetic retinopathy in prediabetes in Asian Indians.
    J Diabetes Complications. 2022 Jan 23:108131.
    >> Share

  287. ARAVINDHAN V, Bobhate A, Sathishkumar K, Viswanathan V, et al
    Serum levels of novel anti-inflammatory cytokine Interleukin-38 in diabetes patients infected with latent tuberculosis (DM-LTB-3).
    J Diabetes Complications. 2022 Jan 22:108133.
    >> Share

  288. PINCU Y, Tryggestad JB, Teague AM, Short KR, et al
    The effect of a high fat meal on heart rate variability and arterial stiffness in adolescents with or without type 1 diabetes.
    J Diabetes Complications. 2022 Jan 14:108130.
    >> Share

  289. ABHINAV RP, Williams J, Bennett C, Livingston P, et al
    Frequency and association of self-reported oral cancer among individuals with type 2 diabetes at a tertiary care diabetes centre in South India - A retrospective study.
    J Diabetes Complications. 2022 Jan 14:108129.
    >> Share

  290. CARDOSO CRL, Leite NC, Salles GF
    Differential effects of treatment targets on risks of adverse outcomes according to diabetes duration, age and complications: Can these characteristics be used to individualize diabetes treatment? The Rio de Janeiro type 2 diabetes cohort.
    J Diabetes Complications. 2022 Jan 13:108124.
    >> Share

  291. HESP AC, Smits MM, van Bommel EJM, Muskiet MHA, et al
    Kidney hemodynamic profile and systemic vascular function in adults with type 2 diabetes: Analysis of three clinical trials.
    J Diabetes Complications. 2022 Jan 11:108127.
    >> Share

  292. NORGAARD CH, Starkopf L, Gerds TA, Malmborg M, et al
    Temporal changes in risk of cardiovascular events in people with newly diagnosed type 2 diabetes with and without cardiovascular disease.
    J Diabetes Complications. 2022 Jan 10:108126.
    >> Share

  293. ABDELAATY T, Morsy E, Rizk M, Shokry A, et al
    Relation of serum heart type fatty acid binding protein to left ventricular diastolic dysfunction in patients with type 2 diabetes and early diabetic kidney disease.
    J Diabetes Complications. 2022 Jan 4:108122. doi: 10.1016/j.jdiacomp.2021.108122
    >> Share

  294. STEIGMANN L, Miller R, Trapani VR, Giannobile WV, et al
    Type 1 diabetes and oral health: Findings from the Epidemiology of Diabetes Interventions and Complications (EDIC) study.
    J Diabetes Complications. 2022 Jan 3:108120. doi: 10.1016/j.jdiacomp.2021.108120
    >> Share

  295. SHAH RD, Braffett BH, Tryggestad JB, Hughan KS, et al
    Cardiovascular risk factor progression in adolescents and young adults with youth-onset type 2 diabetes.
    J Diabetes Complications. 2022 Jan 3:108123. doi: 10.1016/j.jdiacomp.2021.108123
    >> Share

    December 2021
  296. BERGENSTAL RM, Mullen DM, Strock E, Johnson ML, et al
    Randomized comparison of self-monitored blood glucose (BGM) versus continuous glucose monitoring (CGM) data to optimize glucose control in type 2 diabetes.
    J Diabetes Complications. 2021 Dec 31:108106.
    >> Share

  297. MANKOVSKY B
    Editorial commentary to manuscript "Neural correlates of slower gait in middle-aged persons with childhood-onset type 1 diabetes mellitus: The impact of accelerated brain aging" by Royse et al.
    J Diabetes Complications. 2021 Dec 29:108109.
    >> Share

  298. WESTMAN K, Imberg H, Wijkman MO, Hirsch IB, et al
    Effect of liraglutide on markers of insulin production in persons with type 2 diabetes treated with multiple daily insulin injections.
    J Diabetes Complications. 2021 Dec 28:108110.
    >> Share

  299. CARRASCO-TENEZACA F, Barrera-Guarderas F, De la Torre-Cisneros K, Medina-Escudero M, et al
    Time to develop chronic kidney disease in an Ecuadorian Type 2 Diabetes Mellitus cohort: Survival analysis in primary care.
    J Diabetes Complications. 2021 Dec 22:108108.
    >> Share

  300. PARK MS, Jeon J, Song TJ, Kim J, et al
    Association of periodontitis with microvascular complications of diabetes mellitus: A nationwide cohort study.
    J Diabetes Complications. 2021 Dec 22:108107.
    >> Share

  301. DOS SANTOS HABER JF, Chagas EFB, Barbalho SM, Sgarbi JA, et al
    Level of physical activity and gene expression of IL-10 and TNF-alpha in children and adolescents with Type 1 diabetes.
    J Diabetes Complications. 2021 Dec 16:108104.
    >> Share

  302. SPIERA Z, Ilonzo N, Kaplan H, Leitman IM, et al
    Loss of independence as a metric for racial disparities in lower extremity amputation for diabetes: A National Surgery Quality Improvement Program (NSQIP) analysis.
    J Diabetes Complications. 2021 Dec 11:108105.
    >> Share

  303. POLONSKY WH, Fisher L, Hessler D, Desai U, et al
    Toward a more comprehensive understanding of the emotional side of type 2 diabetes: A re-envisioning of the assessment of diabetes distress.
    J Diabetes Complications. 2021 Dec 10:108103.
    >> Share

  304. GUPTA RD, Atri A, Mondal S, Bhattacharjee A, et al
    Characterizing progressive beta-cell recovery after new-onset DKA in COVID-19 provoked A-beta+ KPD (ketosis-prone diabetes): A prospective study from Eastern India.
    J Diabetes Complications. 2021 Dec 9:108100. doi: 10.1016/j.jdiacomp.2021.108100
    >> Share

  305. HANDELSMAN Y, Anderson JE, Bakris GL, Ballantyne CM, et al
    DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases.
    J Diabetes Complications. 2021 Dec 7:108101. doi: 10.1016/j.jdiacomp.2021.108101
    >> Share

  306. POOLE DC
    Can exercise training help redress sexual dimorphism in type II diabetes outcomes?
    J Diabetes Complications. 2021 Dec 7:108099. doi: 10.1016/j.jdiacomp.2021.108099
    >> Share

  307. ZHOU Z, Chen H, Sun M, Jin H, et al
    Fetuin-A to adiponectin ratio is an independent indicator of subclinical atherosclerosis in patients with newly diagnosed type 2 diabetes mellitus.
    J Diabetes Complications. 2021 Dec 3:108102. doi: 10.1016/j.jdiacomp.2021.108102
    >> Share

  308. SIDHU G, Samson R, Nedunchezian SH, Srivastav S, et al
    COVID 19 in-hospital mortality, body mass index and obesity related conditions.
    J Diabetes Complications. 2021;35:108054.
    >> Share

  309. HUANG W, Whitelaw J, Kishore K, Neto AS, et al
    The comparative epidemiology and outcomes of hospitalized patients treated with SGLT2 or DPP4 inhibitors.
    J Diabetes Complications. 2021;35:108052.
    >> Share

    November 2021
  310. GREEN S, Kiely C, O'Connor E, Gildea N, et al
    Differential effects of sex on adaptive responses of skeletal muscle vasodilation to exercise training in type 2 diabetes.
    J Diabetes Complications. 2021 Nov 29:108098.
    >> Share

  311. ZHUO X, Melzer Cohen C, Chen J, Chodick G, et al
    Validating the UK prospective diabetes study outcome model 2 using data of 94,946 Israeli patients with type 2 diabetes.
    J Diabetes Complications. 2021 Nov 14:108086.
    >> Share

  312. ROYSE SK, Costacou T, Nunley KA, Orchard TJ, et al
    Neural correlates of slower gait in middle-aged persons with childhood-onset type 1 diabetes mellitus: The impact of accelerated brain aging.
    J Diabetes Complications. 2021 Nov 14:108084.
    >> Share

  313. NATTERO-CHAVEZ L, Martinez-Garcia MA, Redondo Lopez S, Fernandez-Duran E, et al
    High serum copeptin may be a marker of an increased carotid intima-media thickness in asymptomatic patients with type 1 diabetes.
    J Diabetes Complications. 2021 Nov 11:108085.
    >> Share

  314. VALENTE F, Valente T, Crispim F, Bittencourt CS, et al
    Parents' cardiovascular risk factors are related to overweight and obesity in young Brazilians with type 1 diabetes.
    J Diabetes Complications. 2021 Nov 5:108082. doi: 10.1016/j.jdiacomp.2021.108082
    >> Share

  315. HU X, Yu W, Yang L, Pan W, et al
    First-degree family history of diabetes is associated with nonalcoholic fatty liver disease independent of glucose metabolic status.
    J Diabetes Complications. 2021 Nov 4:108083. doi: 10.1016/j.jdiacomp.2021.108083
    >> Share

  316. KOHZUMA T, Tao X, Koga M
    Glycated albumin as biomarker: Evidence and its outcomes.
    J Diabetes Complications. 2021;35:108040.
    >> Share

  317. TERZO S, Amato A, Mule F
    From obesity to Alzheimer's disease through insulin resistance.
    J Diabetes Complications. 2021;35:108026.
    >> Share

  318. KIM YH, Her AY, Jeong MH, Kim BK, et al
    Comparison of two-year clinical outcomes according to glycemic status and renal function in patients with acute myocardial infarction following implantation of new-generation drug-eluting stents.
    J Diabetes Complications. 2021;35:108019.
    >> Share

    October 2021
  319. GAEBE K, White CA, Mahmud FH, Scholey JW, et al
    Evaluation of novel glomerular filtration rate estimation equations in adolescents and young adults with type 1 diabetes.
    J Diabetes Complications. 2021 Oct 29:108081.
    >> Share

  320. MORIYA T, Hayashi A, Matsubara M, Suzuki A, et al
    Glucose control, diabetic retinopathy, and hemodialysis induction in subjects with normo-microalbuminuric type 2 diabetic patients with normal renal function followed for 15 years.
    J Diabetes Complications. 2021 Oct 29:108080.
    >> Share

  321. SAMANTH J, Padmakumar R, Vasudeva A, Lewis L, et al
    Persistent subclinical myocardial dysfunction among infants of diabetic mothers.
    J Diabetes Complications. 2021 Oct 21:108079.
    >> Share

  322. OZUYNUK AS, Erkan AF, Dogan N, Ekici B, et al
    Examining the effects of the CLU and APOE polymorphisms' combination on coronary artery disease complexed with type 2 diabetes mellitus.
    J Diabetes Complications. 2021 Oct 15:108078.
    >> Share

  323. KHUNTI K, Heerspink HJL, Lam CSP, Nicolucci A, et al
    Design and rationale of DISCOVER global registry in type 2 diabetes: Real-world insights of treatment patterns and its relationship with cardiovascular, renal, and metabolic multimorbidities.
    J Diabetes Complications. 2021 Oct 13:108077.
    >> Share

  324. SEAH JM, Botterill E, MacIsaac RJ, Milne M, et al
    Functional MRI in assessment of diabetic kidney disease in people with type 1 diabetes.
    J Diabetes Complications. 2021 Oct 12:108076.
    >> Share

  325. KATSIKI N, Fonseca V
    Stroke prevention in diabetes with glucagon-like peptide-1 receptor agonists: A game-changer?
    J Diabetes Complications. 2021 Oct 9:108075. doi: 10.1016/j.jdiacomp.2021.108075
    >> Share

  326. SALNA I, Salna E, Pahirko L, Skrebinska S, et al
    Achievement of treatment targets predicts progression of vascular complications in type 1 diabetes.
    J Diabetes Complications. 2021 Oct 8:108072. doi: 10.1016/j.jdiacomp.2021.108072
    >> Share

  327. GUNES M, Temizkan S, Apaydin T, Ilgin C, et al
    Serum osteoprotegerin levels, endothelial function and carotid intima-media thickness in type 2 diabetic patients.
    J Diabetes Complications. 2021 Oct 8:108073. doi: 10.1016/j.jdiacomp.2021.108073
    >> Share

  328. UMAPATHY D, Subramanyam PV, Krishnamoorthy E, Viswanathan V, et al
    Association of Fetuin-A with Thr256Ser exon polymorphism of alpha2-Heremans Schmid Glycoprotein (AHSG) gene in type 2 diabetic patients with overt nephropathy.
    J Diabetes Complications. 2021 Oct 8:108074. doi: 10.1016/j.jdiacomp.2021.108074
    >> Share

  329. WANG BK, Wukich DK, Sambandam S
    Complications from ankle arthrodesis in diabetes-related Charcot foot syndrome.
    J Diabetes Complications. 2021 Oct 6:108071. doi: 10.1016/j.jdiacomp.2021.108071
    >> Share

  330. ZHANG X, Zhou Y, Ma R
    Potential effects and application prospect of angiotensin receptor-neprilysin inhibitor in diabetic kidney disease.
    J Diabetes Complications. 2021 Oct 6:108056. doi: 10.1016/j.jdiacomp.2021.108056
    >> Share

  331. XU Y, Shan X, Wang H
    A nomogram for predicting the risk of new-onset albuminuria based on baseline urinary ACR, orosomucoid, and HbA1c in patients with type 2 diabetes.
    J Diabetes Complications. 2021 Oct 5:108058. doi: 10.1016/j.jdiacomp.2021.108058
    >> Share

  332. TSILINGIRIS D, Makrilakis K, Barmpagianni A, Dalamaga M, et al
    The glycemic status determines the direction of the relationship between red cell distribution width and HbA1c.
    J Diabetes Complications. 2021;35:108012.
    >> Share

    September 2021
  333. KANNENKERIL D, Jung S, Harazny J, Striepe K, et al
    Tissue sodium content correlates with hypertrophic vascular remodeling in type 2 diabetes.
    J Diabetes Complications. 2021 Sep 29:108055.
    >> Share

  334. HITCHEN SA, Lan NSR, Rankin JM, Larbalestier R, et al
    Real-world barriers and safety of initiating sodium-glucose co-transporter 2 inhibitor treatment immediately following an acute cardiac event in people with diabetes.
    J Diabetes Complications. 2021 Sep 29:108057.
    >> Share

  335. SILVEIRA MSVM, Pavin EJ, Cardoso EB, Fanti P, et al
    Emotional burden and care of adults with type 1 diabetes during the COVID-19 pandemic in Brazilian regions.
    J Diabetes Complications. 2021 Sep 28:108053.
    >> Share

  336. PRADEEPA R, Subashini R, Venkatesan U, Ningombam S, et al
    Effect of internal migration on diabetes and metabolic abnormalities in India - The ICMR-INDIAB study.
    J Diabetes Complications. 2021 Sep 25:108051.
    >> Share

  337. CHEN N, Song S, Yang Z, Wu M, et al
    ChREBP deficiency alleviates apoptosis by inhibiting TXNIP/oxidative stress in diabetic nephropathy.
    J Diabetes Complications. 2021 Sep 23:108050.
    >> Share

  338. FAULKNER MS, Smart MJ
    Sleep quality and heart rate variability in adolescents with type 1 or type 2 diabetes.
    J Diabetes Complications. 2021 Sep 22:108049.
    >> Share

  339. LIU J, Li J, Li W, Li N, et al
    Predictive values of serum metabolites in early pregnancy and their possible pathways for gestational diabetes: A nested case-control study in Tianjin, China.
    J Diabetes Complications. 2021 Sep 21:108048.
    >> Share

  340. SAELY CH, Maechler M, Vonbank A, Sprenger L, et al
    Single and joint impact of type 2 diabetes and of congestive heart failure on albuminuria.
    J Diabetes Complications. 2021 Sep 12:108046.
    >> Share

  341. CAI X, Lin C, Yang W, Dagogo-Jack S, et al
    Cardiovascular outcomes of antidiabetes medications by race/ethnicity: A systematic review and meta-analysis.
    J Diabetes Complications. 2021;35:107980.
    >> Share

    August 2021
  342. GOPI S, Gowri P, Panda JK, Sathyanarayana SO, et al
    Insulin gene mutations linked to permanent neonatal diabetes mellitus in Indian population.
    J Diabetes Complications. 2021 Aug 17:108022.
    >> Share

  343. SAKAI T, Aoyama K, Inazumi K, Kikuchi R, et al
    Time in range correlates glycated albumin measured immediately after 2weeks of continuous glucose monitoring.
    J Diabetes Complications. 2021;35:107962.
    >> Share

  344. RAO C, Ping F
    Second-trimester maternal lipid profiles rather than glucose levels predict the occurrence of neonatal macrosomia regardless of glucose tolerance status: A matched cohort study in Beijing.
    J Diabetes Complications. 2021;35:107948.
    >> Share

  345. ZHANG Y, Sun J, Liu L, Qiao H, et al
    A review of biosensor technology and algorithms for glucose monitoring.
    J Diabetes Complications. 2021;35:107929.
    >> Share

    July 2021
  346. MOSTAFA TM, Hegazy SK, Elnaidany SS, Shehabeldin WA, et al
    Nigella sativa as a promising intervention for metabolic and inflammatory disorders in obese prediabetic subjects: A comparative study of Nigella sativa versus both lifestyle modification and metformin.
    J Diabetes Complications. 2021;35:107947.
    >> Share

  347. SONG XT, Fan L, Yan ZN, Rui YF, et al
    Echocardiographic evaluation of the effect of poor blood glucose control on left ventricular function and ascending aorta elasticity.
    J Diabetes Complications. 2021;35:107943.
    >> Share

    April 2021
  348. WIKSTROM J, Liu Y, Whatling C, Gan LM, et al
    Diastolic dysfunction and impaired cardiac output reserve in dysmetabolic nonhuman primate with proteinuria.
    J Diabetes Complications. 2021;35:107881.
    >> Share

  349. ANDERSON J, Meneghini L, Hinnen D, Gill J, et al
    Target attainment in insulin-naive patients at high risk for hypoglycemia: Results from ACHIEVE Control.
    J Diabetes Complications. 2021;35:107831.
    >> Share

    March 2021
  350. GARLA V, Subauste A, Butler J, Lien LF, et al
    The role of sodium glucose co-transporter inhibitors in heart failure prevention.
    J Diabetes Complications. 2021;35:107811.
    >> Share

  351. LUO D, Shi Y, Zhu M, Wang H, et al
    Subclinical lipohypertrophy--Easily ignored complications of insulin therapy.
    J Diabetes Complications. 2021;35:107806.
    >> Share

  352. JIALAL I, Patel A, Devaraj S, Adams-Huet B, et al
    Metabolites that activate the inflammasome in nascent metabolic syndrome.
    J Diabetes Complications. 2021;35:107836.
    >> Share

  353. BLAIR HR, Tomas C, Miwa S, Heath A, et al
    Peroxisomes and pancreatic beta-cell lipo-dysfunction.
    J Diabetes Complications. 2021;35:107843.
    >> Share

    February 2021
  354. QIU M, Ding LL, Zhang M, Zhou HR, et al
    Comparison of the risk of SGLT2is and NonSGLT2is in leading to amputation: A network meta-analysis.
    J Diabetes Complications. 2021;35:107803.
    >> Share

  355. LILJA E, Gottsater A, Miftaraj M, Ekelund J, et al
    The impact of diabetes mellitus on major amputation among patients with chronic limb threatening ischemia undergoing elective endovascular therapy- a nationwide propensity score adjusted analysis.
    J Diabetes Complications. 2021;35:107675.
    >> Share

    January 2021
  356. KIM W, Go T, Kang DR, Lee EJ, et al
    Hemoglobin glycation index is associated with incident chronic kidney disease in subjects with impaired glucose metabolism: A 10-year longitudinal cohort study.
    J Diabetes Complications. 2021;35:107760.
    >> Share

  357. AARTHY R, Aston-Mourney K, Mikocka-Walus A, Radha V, et al
    Clinical features, complications and treatment of rarer forms of maturity-onset diabetes of the young (MODY) - A review.
    J Diabetes Complications. 2021;35:107640.
    >> Share

  358. HIRSCH IB, Gaudiani LM
    A new look at brittle diabetes.
    J Diabetes Complications. 2021;35:107646.
    >> Share

  359. KUMARAN S, Unnikrishnan AG
    Fibrocalculous pancreatic diabetes.
    J Diabetes Complications. 2021;35:107627.
    >> Share

  360. STONE SI, Abreu D, McGill JB, Urano F, et al
    Monogenic and syndromic diabetes due to endoplasmic reticulum stress.
    J Diabetes Complications. 2021;35:107618.
    >> Share

  361. YEUNG RO, Al Jundi M, Gubbi S, Bompu ME, et al
    Management of mitochondrial diabetes in the era of novel therapies.
    J Diabetes Complications. 2021;35:107584.
    >> Share

    December 2020
  362. IIDA M, Ishiguro Y
    Association of prediabetes with impaired left atrial contractility in patients with never-treated hypertension.
    J Diabetes Complications. 2020 Dec 31:107827.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016